Do patients with submassive pulmonary embolism benefit from thrombolytic therapy?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27938515.
- Also identified by DOI 10.3949/ccjm.83a.15116.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Despite growing interest in thrombolytic agents to treat submassive pulmonary embolism, their role in this scenario remains controversial. Needed is a way to identify patients with this condition who are at risk of clinical deterioration and who would benefit from thrombolytic therapy. Here, we review the use of thrombolytic agents in submassive pulmonary embolism to help distinguish the risk and benefits of this therapy.
Medical subject headings
- Pulmonary Embolism
- Thrombolytic Therapy